Bioinformatic analysis of SH2D7 and its encoded protein

  • YANG Hua ,
  • YANG Fengqin ,
  • LIAO Guoling ,
  • LIU Xueying
  • 1. School of Laboratory Medicine, Ningxia Medical University, Yinchuan 750004, China;
    2. Ningxia Institute of Laboratory Medicine, Yinchuan 750004, China

Received date: 2014-07-07

  Revised date: 2014-10-07

  Online published: 2015-02-09


The bioinformatic software is used to predict the nucleotide sequence of SH2D7 and the second structure of its encoding protein. It is shown that SH2D7 is located on the human chromosome 15q25.1, containing six exons and five introns. SH2D7 protein is mainly involved in the regulation of the gene expression and the signal transduction. Its molecular weight is 49.8 kD and the isoelectric point is 5.99. SH2D7 is a hydrophilic protein mainly located in the nucleus and there are 35 phosphorylation sites and 22 epitopes bit in the SH2D7 protein sequence.

Cite this article

YANG Hua , YANG Fengqin , LIAO Guoling , LIU Xueying . Bioinformatic analysis of SH2D7 and its encoded protein[J]. Science & Technology Review, 2015 , 33(2) : 35 -38 . DOI: 10.3981/j.issn.1000-7857.2015.02.003


[1] Orentas R J, Nordlund J, He J, et al. Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison[J]. Frontiers in Oncology, 2014, 4: 134.
[2] Chu C M, Yao C T, Chang Y T, et al. Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta- analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees[J]. Disease Markers, 2014, 2014: 634123.
[3] Leslie R, O'Donnell C J, Johnson A D. GRASP: Analysis of genotypephenotype results from 1390 genome- wide association studies and corresponding open access database[J]. Bioinformatics, 2014, 30(12): i185-i194.
[4] Park S M, Park S J, Kim H J, et al. A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis[J]. Experimental and Molecular Medicine, 2013, 45: e31.
[5] Sousa J F, Torrieri R, Silva R R, et al. Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool[J]. PLoS One, 2010, 5(10): e13510.
[6] Laversin S A, Phatak V M, Powe D G, et al. Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells[J]. Genes Chromosomes Cancer, 2013, 52(3): 316-329.
[7] Aouacheria A, Navratil V, Barthelaix A, et al. Bioinformatic screening of human ESTs for differentially expressedgenes in nomal and tumor tissues[J]. BMC Genomics, 2006, 7: 94.
[8] Barlow D J, Edwards M S, Thornton J M. Continuous and discontinuous protein antigenic determinants[J]. Nature, 1986, 322(6081): 747-748.
[9] Liu W Q, Vidal M, Olszowy C, et al. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs[J]. Journal of Medicinal Chemistry, 2004, 47(5): 1223-1233.
[10] Mandal P K, Ren Z, Chen X, et al. Structure- activity studies of phosphopeptidomimetic prodrugs targeting the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3) [J]. International Journal of Peptide Research and Therapeutics, 2013, 19 (1): 3-12.
[11] Chen K F, Tai W T, Chu P Y, et al. STAT3 mediates regorafenibinduced apoptosis in hepatocellular carcinoma[J]. Clinical Cancer Research, 2014, 20(22): 5768-5776.
[12] Sanz A, Niranjan Y, Hammarén H, et al. The JH2 domain and SH2- JH2 linker regulate JAK2 activity: A detailed kinetic analysis of wild type and V617F mutant kinase domains[J]. Biochimica et Biophysica Acta, 2014, 1844(10): 1835-1841.